BioSpace News Archive

Immune Therapeutics, Inc. d/b/a Biostax Corp (OTC Pink: IMUN) (“Biostax”), a hub and spoke biotech development engine, sadly announces the passing of H. Louis Salomonksy, a dedicated member of its Board of Directors.

Gracell Biotechnologies Inc. today announced that the management team will participate in and attend one-on-one meetings at three upcoming investor conferences.

Matica Biotechnology, Inc. today announced the appointment of Laura Parks as executive vice president of Commercial Operations and Heather N. Sugrue as vice president of Alliance Management.

Now celebrating its 50th Anniversary, the National Foundation for Cancer Research will unite the world’s leading cancer researchers, clinicians, entrepreneurs, and biotech leaders for its 2023 Global Summit and Award Ceremonies for Cancer Research & Entrepreneurship on Saturday, October 21, 2023, at The National Press Club in Washington, D.C.

Today, Mayo Clinic and GE HealthCare announce a strategic healthcare collaboration for research and product development programs aimed to transform the experience of patients and clinicians in the practice of radiology and the delivery of novel therapies.

The Heart Failure Society of America is pleased to announce Randall C. Starling, MD, MPH, Professor of Medicine, Kaufman Center for Heart Failure Treatment and Recovery, Cleveland Clinic Lerner College of Medicine of the Case Western Reserve University and Cleveland Clinic Heart, Vascular, and Thoracic Institute Staff Cardiologist, Robert and Suzanne Tomsich Department of Cardiovascular Medicine, as a recipient of the 2023 HFSA Lifetime Achievement Award.

The Leukemia & Lymphoma Society, the largest nonprofit dedicated to creating a world without blood cancers, is proud to be recognized by the White House Cancer Moonshot for its investment and efforts to promote health equity in the latest Cancer Moonshot Fact Sheet released yesterday by the White House.

After 61 days of observation, NYU Langone Health doctors this month completed the longest-documented case of a genetically engineered pig kidney functioning in a human body.

For more than 135 years, Johnson & Johnson has provided health care products and solutions to people worldwide.

SciTech Development, a clinical-stage pharmaceutical company with a novel and patented drug delivery platform, announced that the company has received IRB approval for its clinical trial protocol for their lead cancer drug candidate, ST-001 nanoFenretinide.